FDA to review Nuvigil for jet lag disorder treatment
Written by: David Castillo on September 30th, 2009
FDA to review Nuvigil for jet lag disorder treatment | 
The U.S. Food and Drug Administration (FDA) is set to review Cephalon’s Nuvigil sleep disorder drug for treatment of jet lag, the drug manufacturer announced last Thursday.
The FDA is expected to make its decision regarding the product by the end of December 2009.
The regulator is reviewing whether Nuvigil is a qualified treatment for “improving wakefulness in patients with excessive sleepiness associated with jet lag disorder due to eastbound travel,” Cephalon described.
Currently, there are no FDA-approved treatments for jet lag disorder.
Under priority review status, the FDA will make its decision whether to approved the drug or not within a six-month period.
Source: Reuters
You must be logged in to post a comment.
Latest Headlines
- More children suffer from insomnia
- Graymark Healthcare Continues to Advance Strategy to Become Nation’s Top Sleep Medicine Provider
- Oral Appliances Can Treat Sleep Apnea
- Sleep behaviors linked to Parkinson’s disease and dementia
- A dental mouthpiece for sleep apnea treatment
- New Sleep Apnea Resource Site Launched
- Sleep disorders—a growing concern in America
- Sleep Center opens its second branch
- Watch a sleep study via live streaming
- European regulators restrict the use of Cephalon
- Rockford, Illinois Sleep Apnea Treatment: I Hate CPAP! Offers Comfortable Alternatives to CPAP. Dental Sleep Medicine and Oral Appliances can Improve Your Sleep and Improve Your Life!
- Searching for a Good Night’s Sleep
- Proper diagnosis is necessary for any sleep disorder
- Graveyard shifts and the sleep disorders they bring
- All about shift work sleep disorder
In The News
Sleep disorder symptoms
You wake up to the alarm
New study links sleep apnea to coronary heart disease
According to a recent study, moderate
New Study Suggests Tart Cherry Juice Can Be a Natural Solution for Insomnia
[PRNewswire] — Drinking tart cherry juice
Global Narcolepsy Therapeutics Market to Reach US$395 Million by 2015, According to New Report by Global Industry Analysts, Inc.
[PRWEB] — Sleep disorders affect millions